Genus PLC
28 February 2006
Genus plc ('the Company')
Additional Listing
Application has been made to the Alternative Investment Market of the London
Stock Exchange ('AIM') for a blocklisting on 1,288,916 ordinary shares of 10p
each to be admitted to trading on AIM.
These shares, ranking pari passu in all respects with the existing shares in
issue, will be allotted pursuant to the exercise of options and to the rules of
the following schemes:
Genus plc 1996 Executive Plan 15,600 shares
Genus plc 1999 Executive Plan 91,800 shares
Genus plc 2000 Company Share Plan Part A 34,807 shares
Genus plc 2000 Company Share Plan Part B 293,969 shares
Genus plc 2004 Company Share Plan Part A 155,634 shares
Genus plc 2004 Company Share Plan Part B 697,106 shares
These shares will not be allotted immediately but as and when the scheme rules
allow.
It is expected that admission will become effective on AIM on 6 March 2006.
28 February 2006
Enquiries:
Genus plc
David Timmins, Group Finance Director
Tel: 01256 347107
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.